Wolff Wiese Magana’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.86K Hold
52
﹤0.01% 500
2026
Q1
$10.3K Sell
52
-1
-2% -$193 0.01% 463
2025
Q4
$9.74K Sell
53
-46
-46% -$8.07K 0.01% 439
2025
Q3
$15.2K Buy
99
+46
+87% +$6.96K 0.01% 368
2025
Q2
$7.41K Hold
53
﹤0.01% 478
2025
Q1
$7.79K Buy
+53
New +$7.67K 0.01% 458
2023
Q3
Sell
-10
Closed -$1.43K 805
2023
Q2
$1.43K Hold
10
﹤0.01% 585
2023
Q1
$1.39K Hold
10
﹤0.01% 548
2022
Q4
$1.36K Sell
10
-51
-84% -$6.4K ﹤0.01% 544
2022
Q3
$7K Hold
61
0.01% 546
2022
Q2
$8K Hold
61
0.01% 559
2022
Q1
$8K Buy
61
+12
+24% +$1.44K 0.01% 561
2021
Q4
$5K Buy
49
+41
+513% +$4.82K ﹤0.01% 624
2021
Q3
$1K Hold
8
﹤0.01% 752
2021
Q2
$1K Hold
8
﹤0.01% 768
2021
Q1
$1K Hold
8
﹤0.01% 687
2020
Q4
$1K Buy
+8
New +$847 ﹤0.01% 640

Other funds holding AZN

Wolff Wiese Magana's AZN Position: Q2 2026 in Review

Wolff Wiese Magana held its AstraZeneca (AZN) position steady in Q2 2026 at 52 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #500.

Wolff Wiese Magana first reported a position in AZN in Q4 2020 and has held it in 17 quarters since. The position peaked at $15.2K in Q3 2025. 503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Wolff Wiese Magana held 52 shares of AstraZeneca worth $9.86K as of Q2 2026.
  • Wolff Wiese Magana left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #500 holding.
  • Wolff Wiese Magana first reported a position in AstraZeneca in Q4 2020 and has held it in 17 quarters since.
  • Wolff Wiese Magana's AstraZeneca position peaked at $15.2K in Q3 2025.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.